These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☐
|
Preliminary Proxy Statement
|
|
☐
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☑
|
Definitive Proxy Statement
|
|
☐
|
Definitive Additional Materials
|
|
☐
|
Soliciting Material Pursuant to §240.14a-12
|
|
☑
|
No fee required.
|
|
|
☐
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
Total fee paid:
|
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
|
|
|
Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
||
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
|
|
Page
|
|
|
Invitation to Shareholders
|
|
|
Notice of Meeting
|
|
|
Proxy Statement
|
1
|
|
Additional Information About the Meeting
|
1
|
|
Internet Availability of Proxy Materials
|
5
|
|
Proxy Solicitation
|
5
|
|
Proposal No. 1 – Election of Directors
|
5
|
|
Governance of the Company
|
6
|
|
Executive Officers
|
12
|
|
Summary Compensation Table
|
13
|
|
Executive Compensation
|
13
|
|
Outstanding Equity Awards as of Fiscal Year-End 2016
|
15
|
|
Security Ownership of Certain Beneficial Owners and Management
|
15
|
|
Section 16(a) Beneficial Ownership Reporting Compliance
|
17
|
|
Certain Relationships and Related Transactions
|
18
|
|
Proposal No. 2 – Ratification of Independent Registered Public Accounting Firm
|
19
|
|
Report of the Audit Committee
|
20
|
|
Proposal No. 3 – Advisory Vote on Executive Compensation
|
21
|
|
Proposal No. 4 – Approval of an Increase in the Amount of the Company's Authorized Common Stock
|
21
|
|
Proposal No. 5 – Approval of an Increase in the Amount of the Company's Authorized Preferred Stock
|
23
|
|
Shareholder Proposals for the 2017 Annual Meeting of Shareholders
|
|
|
Proxy Solicitation and Costs
|
26
|
|
Shareholders Sharing the Same Address
|
26
|
|
Annual Report on Form 10-K
|
26
|
|
Other Business
|
27
|
|
Annex A
|
28
|
|
Annex B
|
29
|
|
Sincerely yours,
|
|
|
/s/ Kelvyn H. Cullimore, Jr.
|
|
|
Kelvyn H. Cullimore, Jr.
|
|
|
Chairman, President and CEO
|
|
1.
|
To elect three directors to hold office until the next annual meeting of the Company's shareholders or until their respective successors have been elected or appointed and qualified ("Proposal No. 1");
|
|
2.
|
To ratify on an advisory basis the appointment of Tanner LLC as our independent registered public accounting firm for the fiscal year ending June 30, 2017 ("Proposal No. 2");
|
|
3.
|
To approve a non-binding advisory "say on pay resolution" regarding the compensation paid to our executive officers ("Proposal No. 3");
|
|
4.
|
To approve an amendment to our Articles of Incorporation increasing the number of shares of common stock the Company is authorized to issue ("Proposal No. 4");
|
|
5.
|
To approve an amendment to our Articles of Incorporation increasing the number of shares of preferred stock the Company is authorized to issue ("Proposal No. 5"); and
|
|
6.
|
To transact such other business that properly comes before the Annual Meeting or any adjournment or postponements thereof.
|
|
BY ORDER OF THE BOARD OF DIRECTORS
|
|
|
/s/ Kelvyn H. Cullimore, Jr.
|
|
|
Kelvyn H. Cullimore, Jr.
|
|
| Chairman, President and CEO |
|
·
|
Elect three members of our board of directors ("Board of Directors" or "Board") to hold office until the next annual meeting of shareholders or until their respective successors have been elected and qualified (Proposal No. 1);
|
|
·
|
Ratify the appointment of Tanner LLC as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2017 (Proposal No. 2);
|
|
·
|
Approve a non-binding advisory resolution concerning the compensation paid to our executive officers or "say on pay resolution" (Proposal No. 3);
|
|
·
|
Approve an amendment to our Articles of Incorporation increasing the number of shares of common stock the Company is authorized to issue (Proposal No. 4);
|
|
·
|
Approve an amendment to our Articles of Incorporation increasing the number of shares of preferred stock the Company is authorized to issue (Proposal No. 5); and
|
|
·
|
Act upon such other matters as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
|
·
|
FOR
each of the nominees of the Board of Directors;
|
|
·
|
FOR
the ratification of the appointment of Tanner LLC as the Company's independent registered public accounting firm for fiscal year 2017;
|
|
·
|
FOR
approval of the say on pay resolution;
|
|
·
|
FOR
approval of the amendment increasing the number of shares of common stock the Company is authorized to issue; and
|
|
·
|
FOR
approval of the amendment increasing the number of shares of preferred stock the Company is authorized to issue.
|
|
Kelvyn H. Cullimore, Jr.
Chairman, Chief Executive Officer and President
Age 60
Director since 1983
|
Mr. Cullimore has been our Chairman since January 2005 and President and Chief Executive Officer since 1992. He served as our Secretary/Treasurer from 1983 to 1992 and as Administrative Vice President from 1988 to 1992. Mr. Cullimore graduated cum laude from Brigham Young University in 1980 with a Bachelor's degree in Financial and Estate Planning. In addition to his involvement with Dynatronics, Mr. Cullimore served as Executive Vice President and a director of our former parent company. Mr. Cullimore has served previously on the board of directors of a printing company, lumber company, theater and restaurant company, and travel agency. He also serves as the Mayor of Cottonwood Heights, Utah, a suburb of Salt Lake City, where the Company corporate headquarters is located. Based on his experience in management and his long association with and effective leadership of the Company, the Nominating and Governance Committee believes Mr. Cullimore is well qualified to serve on our Board.
|
|
|
Scott A. Klosterman
Director
Age 58
|
Mr. Klosterman has been an Executive Vice President at HNI Healthcare since February 2016. Prior to joining HNI Healthcare, Mr. Klosterman served as Vice President and General Manager, Post-Operative Products of Hanger, Inc., a leading provider of prosthetic, orthotic, and therapeutic solutions, from 2010 to 2015. From 2009 to 2010, he was an executive consultant in Chattanooga, Tennessee, providing consulting services to healthcare businesses to help them refine their product development processes and successfully launch new products. Mr. Klosterman was Division President of Chattanooga Group (a division of DJO, Inc., owned by the Blackstone Group), Chattanooga, Tennessee, from 2003 to 2008, where he had previously served as Chief Operating Officer (1997-2003) and Chief Financial Officer, Secretary, Treasurer (1994-1997). Mr. Klosterman has an MBA from Baylor University and a BS in Accounting (with highest honors) from the University of Delaware. Based on Mr. Klosterman's extensive experience in the medical industry, the Nominating and Governance Committee believes that he is well qualified to serve on our Board.
|
|
|
R. Scott Ward, Ph.D.
Director
Age 60
Director since 2013
|
Dr. Ward serves as the chairman of the Department of Physical Therapy at the University of Utah. He is the past president of the American Physical Therapy Association, a position he held from 2006 to 2012. In addition, Dr. Ward served as chair of the rehabilitation committee of the American Burn Association. He has published extensive research studies related to wound care and burn rehabilitation. Dr. Ward received a Bachelor of Arts degree in Physical Therapy and a Doctor of Philosophy degree in Physiology from the University of Utah. Based on Dr. Ward's prominence in his field, and his extensive experience and expertise in physical therapy, the Nominating and Governance Committee believes that Dr. Ward is well qualified to serve as a member of our Board of Directors.
|
|
|
·
|
Understanding of accounting principles generally accepted in the United States of America ("GAAP") and financial statements.
|
|
·
|
Ability to assess the general application of GAAP in connection with accounting for estimates, accruals and reserves.
|
|
·
|
Experience in preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by our financial statements, or experience actively supervising one or more persons engaged in such activities.
|
|
·
|
Understanding of internal control over financial reporting.
|
|
·
|
Understanding of audit committee functions.
|
|
·
|
The shareholder's name and address and the beneficial owner, if any, on whose behalf the nomination is proposed;
|
|
·
|
The shareholder's reason for making the nomination at the annual meeting, and the signed consent of the nominee to serve if elected;
|
|
·
|
The number of shares owned by, and any material interest of, the record owner and the beneficial owner, if any, on whose behalf the record owner is proposing the nominee;
|
|
·
|
A description of any arrangements or understandings between the shareholder, the nominee and any other person regarding the nomination; and
|
|
·
|
Information regarding the nominee that would be required to be included in Dynatronics' proxy statement by the SEC rules, including the nominee's age, business experience for the past five years and any directorships held by the nominee, including directorships held during the past five years.
|
|
·
|
the requirement that at least a majority of the directors meet the standards of independence applicable to the Company;
|
|
·
|
executive sessions of the independent members of the Board of Directors and committee meetings which include individual sessions with representatives of the Company's independent registered public accounting firm, as well as the CFO and CEO; and
|
|
·
|
completion of performance evaluations of the CEO by the Compensation Committee.
|
|
|
Fees
earned or
paid in cash
|
Stock awards
|
Total
|
|||||||||
| Name |
($)
|
($)
|
($)
|
|||||||||
|
(a)
|
(b)
|
(c)
|
(h)
|
|||||||||
|
Howard L. Edwards
(2)
|
$
|
9,334
|
$
|
1,000
|
$
|
10,334
|
||||||
|
Erin S. Enright
|
8,999
|
10,000
|
18,999
|
|||||||||
|
David B. Holtz
|
0
|
9,500
|
9,500
|
|||||||||
|
Scott A. Klosterman
|
0
|
9,500
|
9,500
|
|||||||||
|
Brian M. Larkin
|
7,333
|
7,500
|
14,833
|
|||||||||
|
Richard J. Linder
(3)
|
9,001
|
0
|
9,001
|
|||||||||
|
R. Scott Ward, PhD
|
9,001
|
10,500
|
19,501
|
|||||||||
|
(1)
|
Columns (d) through (g) are omitted from this table as no items of compensation referenced in those columns were paid to the directors during the period covered by the table. Total compensation paid to executive officers who also served as directors during fiscal year 2016 is detailed in the Summary Compensation Table under "Executive Compensation" in this Proxy Statement. Executive officers serving as directors receive no additional compensation for service as directors.
|
|
(2)
|
Mr. Edwards served as a director of the Company from 1997 until December 16, 2015.
|
|
(3)
|
Mr. Linder served as a director from March 23, 2015, until December 16, 2015.
|
|
Officer
|
Position
|
||
|
Name
|
Age
|
Since
|
with Company
|
|
Kelvyn H. Cullimore, Jr.
|
60
|
1983
|
President and CEO
|
|
David A. Wirthlin
|
55
|
2016
|
Chief Financial Officer
|
|
Bryan D. Alsop
|
54
|
2011
|
Vice President of Information Technology
|
|
T. Jeff Gephart
|
55
|
2016
|
Senior Vice President of Sales
|
|
Douglas G. Sampson
|
62
|
2009
|
Vice President of Production and R&D
|
|
Name
and
Principal
Position
|
Year
ended
June 30,
|
Salary
($)
|
Bonus /
Severance
($)
|
Stock
Awards
($)
|
All Other Compensation ($) (Note 1)
|
Total
($)
|
|||||||||||||||
|
(a)
|
(b)
|
(c)
|
(d)
|
(e)
|
(i)
|
(j)
|
|||||||||||||||
|
Kelvyn H. Cullimore, Jr., Chairman,
|
2016
|
$
|
200,000
|
$
|
0
|
$
|
0
|
$
|
28,047
|
$
|
228,047
|
||||||||||
|
President/CEO
|
2015
|
$
|
187,800
|
$
|
0
|
$
|
0
|
$
|
27,804
|
$
|
215,604
|
||||||||||
|
Larry K. Beardall,
|
2016
|
$
|
161,538
|
$
|
613,451
|
$
|
136,000
|
$
|
26,972
|
$
|
937,961
|
||||||||||
|
Executive Vice President
(
Note 2)
|
2015
|
$
|
162,816
|
$
|
0
|
$
|
0
|
$
|
26,089
|
$
|
188,905
|
||||||||||
|
Bryan D. Alsop
|
2016
|
$
|
133,385
|
$
|
0
|
$
|
0
|
$
|
13,760
|
$
|
147,145
|
||||||||||
|
VP Information Technology
|
2015
|
$
|
128,000
|
$
|
0
|
$
|
0
|
$
|
12,995
|
$
|
140,995
|
||||||||||
|
(1)
|
For each of the individuals listed in the table above, amounts indicated under "All Other Compensation" (column (i)) include but are not limited to perquisites including the dollar value of insurance premiums paid with respect to health and dental insurance, use of Company paid automobile, and cellular phone. No single item included in this column exceeds $25,000 or 10% of the total in the category. Columns (e) through (h) are omitted from this table, as no compensation of the types referred to in those columns was paid to the Named Executive Officers during the periods indicated.
|
|
(2)
|
Includes the fair value of 32,000 shares of restricted common stock granted to Beardall on March 2011, pursuant to Mr. Beardall's employment agreement. These shares were valued based on the closing market price on the date of grant and vested fully upon Mr. Beardall's termination on June 6, 2016. Amounts in column (d) include payments made to Mr. Beardall under severance provisions of his employment agreement.
|
|
Stock Awards
|
||||||||||||||||||||
|
Name
(a)
|
Number of
securities
underlying unexercised
options
(#) exercisable
(b)
|
Option
exercise
price
($)
(e)
|
Option
expiration
date
(f)
|
Number of
shares
or units
of stock
that have
not
vested (#)
(g)
|
Market value
of shares
or units of
stock that
have not
vested ($)
(h)
|
|||||||||||||||
|
Kelvyn H. Cullimore, Jr.
Principal Executive Officer
|
10,000
|
$
|
3.34
|
11/20/2025
|
102,000
|
$
|
213,840
|
|||||||||||||
|
Larry K. Beardall
|
0
|
$
|
0.00
|
N/A
|
0
|
0
|
||||||||||||||
|
Bryan D. Alsop
|
5,000
|
$
|
4.15
|
7/28/2019
|
0
|
0
|
||||||||||||||
|
Name of Beneficial Owner
|
Number of
Shares
|
Percent of
Class
|
||||||
|
Stuart M. Essig
|
2,307,545
|
(1)
|
54.6
|
%
|
||||
|
174 Nassau Street #320
|
||||||||
|
Princeton, NJ 08542
|
||||||||
|
Provco Ventures I LP
|
1,058,795
|
(2)
|
25.1
|
%
|
||||
|
795 E. Lancaster Ave. Suite 200
|
||||||||
|
Villanova, PA 19085
|
||||||||
|
Brian Baker
|
207,962
|
(3)
|
4.9
|
%
|
||||
|
25251 Nueva Vista
|
||||||||
|
Laguna Niguel, CA 92677
|
||||||||
|
Jack Henneman and Keryl Rowden
|
207,962
|
(4)
|
4.9
|
%
|
||||
|
C/o NewLink Genetics
|
||||||||
|
2700 Via Fortuna Drive
|
||||||||
|
Terrace II Suite 100
|
||||||||
|
Austin, TX 78746
|
||||||||
|
Stephen Cyman
|
142,492
|
5.1
|
%
|
|||||
|
50760 Metzen Dr.
|
||||||||
|
Chesterfield, MI 48051
|
||||||||
|
(1)
|
Percentage voting power represents voting power with respect to all shares of Common Stock and Series A Preferred on an as-converted basis voting together as a single class. Based on information provided in Schedule 13D filed by Mr. Essig on July 10, 2015, and dividends issued by the Company. Mr. Essig is the husband of Erin S. Enright, a Preferred Director of the Company. Amount indicated includes 880,000 shares of Common Stock issuable upon conversion of Series A Preferred Stock owned of record by Mr. Essig, 1,320,000 shares of Common Stock issuable upon exercise of warrants held by Mr. Essig, 87,545 shares of Common Stock from Series A Preferred Stock dividends, and 7,604 shares of Common Stock from service on the Company's Board of Directors. Mr. Essig has sole voting and dispositive power of all shares, excluding those issued for Board service; neither Ms. Enright nor Prettybrook Partners, LLC has shared voting or dispositive power over these shares. The mailing address of this shareholder is 311 C, Enterprise Drive, Plainsboro, NJ 08536.
|
|
(2)
|
Percentage voting power represents voting power with respect to all shares of Common Stock and Series A Preferred on an as-converted basis voting together as a single class. Based on information provided in Schedule 13D filed by Provco Ventures I, LP on July 10, 2015. The General Partner of Provco Ventures I, LP is Provco, LLC. The sole member of Provco, LLC is Richard E. Caruso, Ph.D. Amount indicated includes 400,000 shares of Series A Preferred stock convertible into 400,000 shares of Common Stock, warrants to purchase 600,000 shares of Common Stock, and 39,795 shares of Common Stock from Series A Preferred Stock dividends. The mailing address of this shareholder is 311 C, Enterprise Drive, Plainsboro, NJ 08536.
|
|
(3)
|
Percentage voting power represents voting power with respect to all shares of Common Stock and Series A Preferred on an as-converted basis voting together as a single class. Based on information provided in Schedule 13G, filed July 10, 2015. Amount indicated includes 80,000 shares of Common Stock issuable upon conversion of 80,000 shares of Series A Preferred, 120,000 shares of Common Stock issuable upon the exercise of warrants held by the shareholder, and 7,962 shares of Common Stock from Series A Preferred Stock dividends. The mailing address of this shareholder is c/o Seaspine Holdings Corporation, 2302 La Mirada Drive, Vista, CA 92081.
|
|
Name of Beneficial Owner
|
Number of
Shares
|
Percent of
Class
|
||||||
|
Directors and Director Nominees
|
||||||||
|
Kelvyn H. Cullimore, Jr. (CEO/Director)
|
203,258
|
(1)
|
7.0
|
%
|
||||
|
Erin S. Enright (Director)
|
2,307,545
|
(2)
|
54.9
|
%
|
||||
|
David B. Holtz (Director)
|
7,224
|
(3)
|
*
|
|||||
|
Scott A. Klosterman (Director)
|
7,224
|
*
|
||||||
|
Brian M. Larkin (Director)
|
109,687
|
(4)
|
3.7
|
%
|
||||
|
R. Scott Ward (Director)
|
8,913
|
*
|
||||||
|
Named Executive Officers
|
||||||||
|
Larry K. Beardall (Executive VP)
(5)
|
1,540
|
*
|
||||||
|
Bryan D. Alsop (VP of Information Technology)
|
5,000
|
(6)
|
*
|
|||||
|
All executive officers and directors as a group
|
2,733,613
|
63.9
|
%
|
|||||
|
(11 persons)
(7)
|
||||||||
|
(1)
|
Includes 115,258 shares owned directly, 72,000 shares of restricted Common Stock that vest upon retirement, change of control or death, 10,000 shares owned by Mr. Cullimore's wife, and options for the purchase of 6,000 shares.
|
|
(2)
|
Percentage voting power represents voting power with respect to all shares of Common Stock and Series A Preferred on an as-converted basis voting together as a single class. Amount indicated includes 880,000 shares of Common Stock issuable upon conversion of Series A Preferred Stock owned of record by Mr. Essig, 1,320,000 shares of Common Stock issuable upon exercise of warrants held by Mr. Essig, 87,545 shares of Common Stock from Series A Preferred Stock dividends, and 7,604 shares of Common Stock from service on the Company's Board of Directors. Mr. Essig is the husband of Erin S. Enright. Mr. Essig has sole voting and dispositive power of all shares of Preferred Stock, excluding those issued for Board service; neither Ms. Enright nor Prettybrook Partners, LLC has shared voting or dispositive power over these shares.
|
|
(3)
|
Includes 7,224 shares of Common Stock owned directly. Mr. Holtz is an executive officer of Provco, LLC, the general partner of Provco Ventures I LP. The sole member of Provco, LLC is Richard E. Caruso, Ph.D.
|
|
(4)
|
Percentage voting power represents voting power with respect to all shares of Common Stock and Series A Preferred on an as-converted basis voting together as a single class. Amount indicated includes 40,000 shares of Common Stock issuable upon conversion of 40,000 shares of Series A Preferred, 60,000 shares of Common Stock issuable upon the exercise of warrants held by Mr. Larkin, 3,098 shares of Common Stock from Series A Preferred Stock dividends, and 5,704 shares of Common Stock from service on the Company's Board of Directors.
|
|
(5)
|
Mr. Beardall's employment was terminated in May 2015; he is a "Named Executive Officer" for other purposes in this Proxy Statement and is therefore included in this table. As of the Table Date he was not the beneficial owner of any shares of the Company's Common Stock.
|
|
(6)
|
Includes options for the purchase of 5,000 shares.
|
|
(7)
|
In addition to the names listed above, this group includes T. Jeff Gephart, Senior Vice President of Sales; Douglas G. Sampson, Vice President of Production and R&D; and Terry M. Atkinson, Director of Accounting.
|
|
Plan Category
|
Number of
securities to
be issued upon exercise of outstanding
options,
warrants and
rights
(a)
|
Weighted-
average
exercise
price
of outstanding
options,
warrants
and rights
(b)
|
Number of
securities
remaining
available for
future
issuance under
equity
compensation
plans (excluding securities
reflected in
column
(a))
(c)
|
|||||||||
|
Equity compensation plans approved by security holders
|
193,557
|
$
|
2.41
|
405,404
|
||||||||
|
Equity compensation plans not approved by security holders
|
-
|
-
|
-
|
|||||||||
|
Total
|
193,557
|
405,404
|
||||||||||
|
·
|
The fact of such common directorship or financial interest is disclosed or known by our Board of Directors or committee and noted in the minutes, and our Board of Directors or committee authorizes, approves or ratifies the contract or transaction in good faith by a vote for that purpose without counting the vote or votes of such interested directors; or
|
|
·
|
The fact of such common directorship or financial interest is disclosed to or known by the shareholders entitled to vote, and they approve or ratify the contract or transaction in good faith by a majority vote or written consent of shareholders holding a majority of the shares of Common Stock entitled to vote (the votes of the interested directors or officers shall be counted in any such vote of shareholders); or
|
|
·
|
The contract or transaction is fair and reasonable to us at the time it is authorized or approved.
|
|
Respectfully submitted:
|
|
|
THE AUDIT COMMITTEE
|
|
|
David Holtz, Chairman
|
|
|
Erin S. Enright
|
|
|
Scott A. Klosterman
|
|
·
|
1,610,000 shares of Common Stock issuable upon conversion of the Series A Preferred;
|
|
·
|
1,207,500 shares of Common Stock issuable upon exercise of A-Warrants held by the Series A Preferred investors;
|
|
·
|
1,207,500 shares of Common Stock issuable upon exercise of B-Warrants held by the Series A Preferred investors;
|
|
·
|
121,557 shares of Common Stock issuable upon exercise of stock options granted under stock incentive and equity incentive plans of the Company, vested and unvested;
|
|
·
|
405,404 shares of Common Stock reserved for issuance pursuant to future awards under the Company's 2015 Equity Incentive Award Plan;
|
|
·
|
72,000 shares of Common Stock subject to restricted stock awards.
|
|
DYNATRONICS CORPORATION
|
|
|
By order of the Board of Directors
|
|
|
/s/ Kelvyn H. Cullimore, Jr.
|
|
|
Kelvyn H. Cullimore, Jr.
|
|
|
Chairman, President and CEO
|
|
1.
|
That the Articles of Incorporation of the Corporation be amended and restated to include the following change to the authorized capital stock of the Corporation as follows:
|
|
|
a.
|
The number of authorized shares of Common Stock, no par value, of the Corporation shall be increased from 50,000,000 shares to 100,000,000 shares; and
|
|
|
b.
|
Said increase shall not affect the number of shares currently issued and outstanding or the par value of the shares.
|
|
|
2.
|
That the Board of Directors of the Corporation shall amend and restate the Articles of Incorporation as provided in Section 16-10a-1007 of the Utah Revised Business Corporation Act to include this and all prior amendments to the Corporation's Articles of Incorporation to date as currently in effect."
|
|
|
1.
|
That the Articles of Incorporation of the Corporation be amended and restated to include the following change to the authorized capital stock of the Corporation as follows:
|
|
|
a.
|
The number of authorized shares of Preferred Stock, no par value, of the Corporation shall be increased from 5,000,000 shares to 50,000,000 shares; and
|
|
|
b.
|
Said increase shall not affect the par value, number, designation, rights or preferences of any series of preferred shares currently issued and outstanding.
|
|
|
2.
|
That the Board of Directors of the Corporation shall amend and restate the Articles of Incorporation as provided in Section 16-10a-1007 of the Utah Revised Business Corporation Act to include this and all prior amendments to the Corporation's Articles of Incorporation to date as currently in effect."
|
|
|
1.
|
ELECTION OF THREE (3) DIRECTORS TO SERVE FOR A ONE-YEAR PERIOD UNTIL THEIR SUCCESSORS HAVE BEEN ELECTED AND QUALIFIED:
|
|
WITHHOLD AUTHORITY
|
FOR ALL
|
||
|
_________ FOR ALL
|
________ TO VOTE FOR ALL
|
________EXCEPT
|
|
|
2.
|
RATIFICATION OF THE APPOINTMENT OF TANNER LLC AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR FISCAL YEAR ENDING JUNE 30, 2017:
|
|
3.
|
APPROVAL ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT:
|
|
4.
|
APPROVAL OF AN AMENDMENT TO THE COMPANY'S ARTICLES OF INCORPORATION INCREASING THE NUMBER OF SHARES OF COMMON STOCK THE COMPANY IS AUTHORIZED TO ISSUE:
|
|
5.
|
APPROVAL OF AN AMENDMENT TO THE COMPANY'S ARTICLES OF INCORPORATION INCREASING THE NUMBER OF SHARES OF PREFERRED STOCK THE COMPANY IS AUTHORIZED TO ISSUE:
|
|
______________________
|
_______________________________________________________
|
|
(Number of Shares Owned)
|
(Please print or type name exactly as it appears on stock certificate)
|
|
_____________________
|
_______________________________________________________
|
|
(Date)
|
(Signature)
|
|
_______________________________________________________
|
|
|
(Signature of joint owner)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|